HIGHLIGHTS
SUMMARY
Because of their streamlined procedures and emphasis on use of existing data, pragmatic clinical trials may also offer novel ways of adapting to major disruptions, such as those resulting from the COVID-19 pandemic. Survey themes of interest ranged from broad (e_g, "How has COVID-19 impacted your trial?") to specific (e_g, "Which key individuals or stakeholders have you engaged due to COVID-19?"). In this qualitative study, the authors characterized the impact of COVID-19 on research activities of 14 pragmatic clinical trials in the NIH Health Care Systems Research Collaboratory. Given that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.